Warning letters, 483s, Recalls, Import Alerts, Audit observations
The U.S. FDA issued a warning letter to International Laboratories Corp. (FEI 3006403166) following CGMP
USFDA had inspected the Jiangsu Hengrui Pharma’s Huanghe road site in January 2024. The site
USFDA 483 / UCB Farchim SA/ June 2023 / Gaps in Data Integrity program, lack
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
FDA has published the USFDA form 483 issued to Ipca Laboratories Ltd following inspection at
